196 related articles for article (PubMed ID: 29272056)
1. Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
Head Neck; 2018 Apr; 40(4):728-739. PubMed ID: 29272056
[TBL] [Abstract][Full Text] [Related]
2. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
[TBL] [Abstract][Full Text] [Related]
3. Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma.
Baumeister P; Canis M; Reiter M
PLoS One; 2018; 13(10):e0205712. PubMed ID: 30347001
[TBL] [Abstract][Full Text] [Related]
4. Utility of the Surgical Apgar Score in Head and Neck Squamous Cell Carcinoma.
Prince AC; Day KE; Lin CP; Greene BJ; Carroll WR
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):466-472. PubMed ID: 29870298
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection.
Zhou S; Yuan H; Wang J; Hu X; Liu F; Zhang Y; Jiang B; Zhang W
Future Oncol; 2020 Apr; 16(10):559-571. PubMed ID: 32166977
[No Abstract] [Full Text] [Related]
6. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
Farquhar DR; Masood MM; Lenze NR; Sheth S; Patel SN; Lumley C; Zanation AM; Weissler MC; Olshan AF; Hackman TG
Laryngoscope; 2021 Feb; 131(2):E479-E488. PubMed ID: 32449832
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.
Talmi YP; Takes RP; Alon EE; Nixon IJ; López F; de Bree R; Rodrigo JP; Shaha AR; Halmos GB; Rinaldo A; Ferlito A
Head Neck; 2018 May; 40(5):1082-1090. PubMed ID: 29394461
[TBL] [Abstract][Full Text] [Related]
8. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
9. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
[TBL] [Abstract][Full Text] [Related]
10. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and selection criteria in the retreatment of head and neck cancers.
May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE
Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
[TBL] [Abstract][Full Text] [Related]
13. Approximation of head and neck cancer volumes in contrast enhanced CT.
Dejaco D; Url C; Schartinger VH; Haug AK; Fischer N; Riedl D; Posch A; Riechelmann H; Widmann G
Cancer Imaging; 2015 Sep; 15():16. PubMed ID: 26419914
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
Abouhashem NS; Elwan A; Elaidy NF
Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
[TBL] [Abstract][Full Text] [Related]
16. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
[TBL] [Abstract][Full Text] [Related]
17. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
[TBL] [Abstract][Full Text] [Related]
18. Defining secure surgical bone margins in head and neck squamous cell carcinomas: The diagnostic impact of intraoperative cytological assessment of bone resection margins compared with preoperative imaging.
Nieberler M; Stimmer H; Rasthofer D; Nentwig K; Weirich G; Wolff KD
Oral Oncol; 2020 Mar; 102():104579. PubMed ID: 32062159
[TBL] [Abstract][Full Text] [Related]
19. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D
Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961
[TBL] [Abstract][Full Text] [Related]
20. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]